(RTTNews) - Moderna, Inc. (MRNA) announced a revised supply agreement with the Government of Canada for up to 105 million doses of the company's COVID-19 vaccine and its booster vaccine candidate, for delivery through 2024. The deal provides for 20 million doses each year in 2022 and 2023, with an option for an additional 15 million doses each year. For 2024, the agreement includes an option for up to 35 million doses.
Last week, Moderna announced a Memorandum of Understanding with the government of Canada to build a state-of-the-art messenger RNA vaccine manufacturing facility in Canada.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
